Lymphoid enhancer-binding factor 1 explained

Lymphoid enhancer-binding factor 1 (LEF1) is a protein that in humans is encoded by the LEF1 gene.[1] It is a member of T cell factor/lymphoid enhancer factor (TCF/LEF) family.

Function

Lymphoid enhancer-binding factor-1 (LEF1) is a 48-kD nuclear protein that is expressed in pre-B and T cells. It binds to a functionally important site in the T-cell receptor-alpha (TCRA) enhancer and confers maximal enhancer activity. LEF1 belongs to a family of regulatory proteins that share homology with high mobility group protein-1 (HMG1).[2]

Clinical significance

LEF1 is highly overexpressed and associated with disease progression and poor prognosis in B-cell chronic lymphocytic leukemia[3] and other kinds of malignancies like colorectal cancer.[4] It is also a promising potential drug target.[5]

Interactions

Lymphoid enhancer-binding factor 1 has been shown to interact with:

Further reading

Notes and References

  1. Milatovich A, Travis A, Grosschedl R, Francke U . Gene for lymphoid enhancer-binding factor 1 (LEF1) mapped to human chromosome 4 (q23-q25) and mouse chromosome 3 near Egf . Genomics . 11 . 4 . 1040–1048 . December 1991 . 1783375 . 10.1016/0888-7543(91)90030-I . free .
  2. Web site: Entrez Gene: LEF1 lymphoid enhancer-binding factor 1.
  3. Erdfelder F, Hertweck M, Filipovich A, Uhrmacher S, Kreuzer KA . High lymphoid enhancer-binding factor-1 expression is associated with disease progression and poor prognosis in chronic lymphocytic leukemia . Hematology Reports . 2 . 1 . e3 . January 2010 . 22184516 . 3222268 . 10.4081/hr.2010.e3 .
  4. Eskandari E, Mahjoubi F, Motalebzadeh J . An integrated study on TFs and miRNAs in colorectal cancer metastasis and evaluation of three co-regulated candidate genes as prognostic markers . Gene . 679 . 150–159 . December 2018 . 30193961 . 10.1016/j.gene.2018.09.003 . 52172531 .
  5. Gandhirajan RK, Staib PA, Minke K, Gehrke I, Plickert G, Schlösser A, Schmitt EK, Hallek M, Kreuzer KA . 6 . Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo . Neoplasia . 12 . 4 . 326–335 . April 2010 . 20360943 . 2847740 . 10.1593/neo.91972 .
  6. Boras K, Hamel PA . Alx4 binding to LEF-1 regulates N-CAM promoter activity . The Journal of Biological Chemistry . 277 . 2 . 1120–1127 . January 2002 . 11696550 . 10.1074/jbc.M109912200 . free .
  7. Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW . A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia . The Journal of Biological Chemistry . 275 . 1 . 651–656 . January 2000 . 10617663 . 10.1074/jbc.275.1.651 . free .
  8. Edlund S, Lee SY, Grimsby S, Zhang S, Aspenström P, Heldin CH, Landström M . Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis . Molecular and Cellular Biology . 25 . 4 . 1475–1488 . February 2005 . 15684397 . 548008 . 10.1128/MCB.25.4.1475-1488.2005 .
  9. Grueneberg DA, Pablo L, Hu KQ, August P, Weng Z, Papkoff J . A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway . Molecular and Cellular Biology . 23 . 11 . 3936–3950 . June 2003 . 12748295 . 155208 . 10.1128/MCB.23.11.3936-3950.2003 .
  10. Behrens J, von Kries JP, Kühl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W . Functional interaction of beta-catenin with the transcription factor LEF-1 . Nature . 382 . 6592 . 638–642 . August 1996 . 8757136 . 10.1038/382638a0 . 1996Natur.382..638B . 4369341 .
  11. Labbé E, Letamendia A, Attisano L . Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways . Proceedings of the National Academy of Sciences of the United States of America . 97 . 15 . 8358–8363 . July 2000 . 10890911 . 26952 . 10.1073/pnas.150152697 . 2000PNAS...97.8358L . free .
  12. Barolo S, Posakony JW . Three habits of highly effective signaling pathways: principles of transcriptional control by developmental cell signaling . Genes & Development . 16 . 10 . 1167–1181 . May 2002 . 12023297 . 10.1101/gad.976502 . . 1170 . 14376483 . In ... zebrafish, reporter transgenes containing the TOPFLASH promoter are expressed in certain Wnt-responsive cell types (...Dorsky et al. 2002). . free .
  13. Hecht A, Stemmler MP . Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4 . The Journal of Biological Chemistry . 278 . 6 . 3776–3785 . February 2003 . 12446687 . 10.1074/jbc.M210081200 . free .
  14. Yasumoto K, Takeda K, Saito H, Watanabe K, Takahashi K, Shibahara S . Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling . The EMBO Journal . 21 . 11 . 2703–2714 . June 2002 . 12032083 . 126018 . 10.1093/emboj/21.11.2703 .
  15. Sachdev S, Bruhn L, Sieber H, Pichler A, Melchior F, Grosschedl R . PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies . Genes & Development . 15 . 23 . 3088–3103 . December 2001 . 11731474 . 312834 . 10.1101/gad.944801 .